Page last updated: 2024-10-17

citric acid, anhydrous and Tumor Lysis Syndrome

citric acid, anhydrous has been researched along with Tumor Lysis Syndrome in 1 studies

Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.

Tumor Lysis Syndrome: A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bunchman, TE1
Maxvold, NJ1
Barnett, J1
Hutchings, A1
Benfield, MR1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Evaluation of a Simplified Protocol for Regional Citrate Anticoagulation in Continuous Venovenous Hemodiafiltration[NCT00583765]20 participants (Actual)Observational2005-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for citric acid, anhydrous and Tumor Lysis Syndrome

ArticleYear
Pediatric hemofiltration: Normocarb dialysate solution with citrate anticoagulation.
    Pediatric nephrology (Berlin, Germany), 2002, Volume: 17, Issue:3

    Topics: Adolescent; Anticoagulants; Bicarbonates; Child; Child, Preschool; Citric Acid; Dialysis Solutions;

2002